Showing results (621-630 of 721) with videos related to
Sort By:
Pageof 73
Surgery Open Science|March 7, 2023
The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralizationBenjamin D Powers, Kelvin Allenson, Jennifer A Perone, et al.Annals of Surgical Oncology|February 8, 2008
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancerRosa F Hwang, Huamin Wang, Axbal Lara, et al.The American Journal of Surgical Pathology|February 4, 2012
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.The American Journal of Surgical Pathology|July 23, 2015
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal AdenocarcinomaLi Liu, Matthew H Katz, Sun M Lee, et al.Biomaterials|January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapyJun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB ActivationZhuonan Zhuang, Huai-Qiang Ju, Mitzi Aguilar, et al.Pageof 73